<span>Labcorp opens new Los Angeles based laboratory</span>
December 8, 2022

Labcorp opens new Los Angeles based laboratory

New Space Will Be Three Times Larger and Increase Testing Capabilities BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 8, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in
Read more »

The Clinical Relevance of Anti-DFS70 Autoantibodies

Presentation on the use of the anti-DFS70 antibodies to help identify ANA-positive individuals who do not have an ANA-associated autoimmune disease (AARD), especially in the absence of significant clinical findings.

Speaker

Vincent Ricchiuti, PhD Laboratory Director and Discipline Director in Immunology, Labcorp

Webinars

Cases in Biologic and other Specialized Therapeutic Drug Monitoring

Presentation on the use of traditional and biologic therapeutic drug monitoring to help physicians optimize the management of rheumatic disorders.

Speaker

Jane Yang, MD, Medical Science Director, Labcorp

Webinars
<span>Empower yourself with answers about colon cancer</span>
December 2, 2022

Empower yourself with answers about colon cancer

Colon cancer. You might not want to think about it, but as the third leading cause of cancer deaths in adults in the United States, it is certainly worth talking about with your doctor. Let’s learn the basics and what you can do to improve your odds.
Read more »
November 30, 2022

Statement regarding Cambodian NHP supply

The November 16, 2022, indictment filed against the Cambodian breeder and Cambodian officials does not name or reference Labcorp.  The Early Development business has multiple global suppliers and requires its vendors to meet high regulatory compliance standards.  Ex-US sites do not use Cambodian NHP supply. The business is working to procure additional supply from other sources for our US operations. US NHP studies comprise less than 2% of overall enterprise Labcorp revenue.  
Read more »